2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92546°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
ÀÏ·ë, º½ ÀÎÅ׸®¾î ½ÃÁð ¸Â¾Æ ¸®ºù ½ÅÁ¦Ç° (2019-03-21)
µµ·ÎºÐÁøÃ»¼Ò·Î PM-2.5 ¹ß»ý¿ø 16.5Åæ Á¦°Å (2018-11-08)
µÎīƼ ÄÚ¸®¾Æ, ½ºÅ©·¥ºí·¯ SUMMER ÇÑÁ¤ ÇÁ·Î¸ð¼Ç (2019-06-21)
Ãִ뼺, À¯Æ©ºê ¹æ¼Û¼­ ¿µÅ¹°ú ÀüÈ­ÅëÈ­ (2022-01-17)
Ãʱ³»ýÀÌ Ã¹ ¿ù±ÞÀ¸·Î ÇÏ°í ½ÍÀº °Í? (2014-10-27)
¿¤Ä­Åä-¿¬¼¼´ë, ÄÜÅÙÃ÷ ¹× ±â¼ú Áö¿ø »óÈ£Çù·Â (2021-09-06)
LGÀ¯Ç÷¯½º, ±¹³» ÃÖÃÊ ÁýÀüÈ­ ¹«Á¦ÇÑ ¿ä±ÝÁ¦ (2014-09-16)
Á¤ºÎÁö¿ø ¿¬±¸ °æÀï·Â, ÅõÀÔ¿¹»ê ´ëºñ ³Ê¹« ³·´Ù (2018-12-29)
ÀÚ¿¬Ä¡À¯¡¤Ä§¡¤¿îµ¿ µî ¸ÂÃãÇü ¾Ï ¸é¿ª¿ä¹ýÀ¸·Î ¾Ï Ä¡À¯ (2013-05-13)
¾Èµ¿ ¹Î´ã ¼ÒÀç À¥Å÷ ¡®Á¦ºñ¿ø À̾߱⡯ (2013-08-13)
±â¾ÆÂ÷, 2021 ½î¿ï / ½î¿ï EV Ãâ½Ã (2020-03-23)
´õÇ÷¹À̽º, ¿¬¸»¸ÂÀÌ ½ºÅ×ÀÌÅ© 3Á¾ Ãâ½Ã (2019-11-11)
â´ö±Ã°ü¸®¼Ò, ±Ã±È ¸ð³»±â Çà»ç °³ÃÖ (2013-05-23)
Pharma Proposes to Work with G7 and G20 on a Joint Solution ... (2022-07-20)
¿ÃÇØ ÁÖ¸ñÇØ¾ß ÇÒ 4´ë º¸¾È À§Çù (2022-03-09)
û¼Ò³â 81.8%, ½º¸¶Æ®Æù ¼ÒÅë¿¡ µµ¿òµÅ ±àÁ¤Àû (2012-11-30)
APAC ³×Æ®¿öÅ© º¸¾È ½ÃÀå ¼ºÀå (2021-10-27)
¡®Çб³°ø°£Çõ½Å»ç¾÷¡¯ »ç¿ëÀÚ Âü¿©Çü ¼ö¾÷ Çõ½Å (2020-01-01)
¿ÃÇØ ħ±¸ ¼Òºñ Æ®·»µå´Â ¼¼·ÃµÈ ¼Òºñ ¡®½ÃÅ©¡¯ (2020-01-01)
New Samsung Galaxy A80: Built for the Era of Live (2019-04-10)
2030 ¿©¼º 68%, ¾Æ¹«¸® Ãß¿öµµ ¹Ì´Ï½ºÄ¿Æ® ÀԴ´٠(2013-12-03)
Health Professionals Petition CDC for Guidance: Americans Us... (2020-12-24)
±¹Åä±³ÅëºÎ, ¡®ÀÚÀ²ÁÖÇàÂ÷ À±¸® Áöħ¡¯ Á¦Á¤ (2020-08-13)
½ÃµðÁî, ÀÇÀÚ°¡ º¸³»´Â ÀÀ¿ø ¡®±â´ë¿ä¡¯ ÇÁ·ÎÁ§Æ® (2019-02-28)
»ï¼ºÀüÀÚ ºê·£µå °¡Ä¡ 126Á¶¿ø¡¦ 9.4% »ó½Â (2019-02-28)
       [ÀÌÀü][1]....[3137][3138][3139][3140][3141][3142][3143][3144][3145]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..